News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
planta de producción natac
Natac is placed in the top 15 companies by return in Horizon Europe
Agrifood · Industrial biotechnology
joel jean
Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline
Industrial biotechnology · Financing
Financing led by TCGX, including new investment from TPG, Orbimed Advisors, Venrock Healthcare…
Danio
Biobide presented about Toxicity topics for Drug Discovery in Japan
Healthcare · Agrifood · International · Communication · Corporate
"Testicular Toxicity Assessment using Zebrafish" and "Validation and Qualification of New…
estudio
BCN HEALTH publishes a study evaluating the relationship between kidney failure, heart diseases and the occurrence of hyperkalemia
Healthcare · Access to innovation
BCN HEALTH has published the study ‘Relationship between a diagnosis of kidney failure and heart…
entrevista nostrum
Polypharmacology as the Future of Drug Design
Healthcare · Innovative drugs
simbionte
#NewAseBioMember | "AseBio provides a wealth of information on trends and advancements in the sector, which will enable us to be agile in seizing opportunities"
Industrial biotechnology · Communication · Digitalization
Meet SIMBIONTE, our new member. We spoke with Manuel Esbrí Ramos, co-founder.
nano
LeishGen: Advanced Genomic Platforms for Drug Resistance Biomarkers in Leishmania infantum
Healthcare · Access to innovation · Antibiotic resistance
LeishGenApp and LeishGenR are Nano1Health’s cutting-edge solutions for detecting drug resistance…
tebrio
Tebrio secures €30 million in funding from Banco de Santander, Sodical, GPC and CDTI
Industrial biotechnology · Financing
The company, based in Salamanca, expects to triple its workforce in the next two years. This is…
gate2brain
Gate2Brain Receives EMA Orphan Drug Designation for Its Groundbreaking Pediatric Cancer Treatment
Healthcare · Innovative drugs